The Life Sciences sector in Selangor is of significant interest to potential investors, offering promising prospects in four key industries.
Aligned with MIDA’s categorization, this sector fosters innovation and growth, solidifying Selangor’s position as a thriving investment hub for the life sciences.
Within this dynamic landscape, the Medical Devices industry contributes significantly through continuous advancements that enhance patient care and diagnostics, resulting in improved health outcomes and an enriched quality of life.
Similarly, the Pharmaceuticals industry plays a pivotal role by encompassing extensive research, development, and medicine production, enhancing treatments and making significant contributions to public health and well-being.
Furthermore, the Biotechnology industry emerges as a transformative force, harnessing cellular and biomolecular processes to address various challenges. It leads to advancements in sustainable agriculture, healthcare, and environmental solutions.
Simultaneously, the Cosmetics, Toiletries, and Personal Care industry emphasizes well-being and societal wellness through self-care product promotion, aligning with Selangor’s holistic growth approach.
Collectively, these industries define Selangor’s role in driving innovation, nurturing growth, and inviting investments that align with global well-being goals.
Selangor's life sciences sector offers a compelling value proposition, distinguished by its core strengths that cater to the sector's specific needs.
The region boasts a Thriving Ecosystem, where research and startups flourish, fostering sustainable growth within the life sciences sector.
With a Skilled Workforce readily available, Selangor meets the industry’s diverse demands, ensuring a robust talent pool to drive innovation and development.
Moreover, Selangor leverages its Strategic Advantage as an ASEAN gateway, positioning itself as a pivotal life sciences hub. This strategic location attracts both foreign and local companies, drawn by the advanced facilities and well-established infrastructure.
Selangor Biotechnology Action Plan 2021-2030
Aim to further flourish the Biotechnology sector in Selangor and positioning Selangor to be more attractable to the investors by making Selangor as a Regional Biotechnology Hub.
The Selangor Biotechnology Action Plan 2021-2030 (SBAP 2021-2030) was commissioned by Invest Selangor and was produced by Malaysian Bioeconomy Development Corporation (Bioeconomy Corporation), Universiti Putra Malaysia (UPM) and Malaysian Biotechnology Information Centre (MABIC). The SBAP 2021-2030 aims to align and guide various ecosystem stakeholders to make Selangor as the regional biotechnology hub for innovation, technology dissemination, investment and human capital development.
The SBAP encompasses five main strategic thrusts:
1. Effective Governance and Leadership
2. Enabling Business and R&D Infrastructure
3. Sustainable Investment and Funding
4. Talent Enhancement and Professional Development
5. Biotechnology Sector Development